Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- no data
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Peer-reviewed publication with summarized results. The study was GLP complient and performed according to OECD guideline 413.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Details on test material:
- purity grade: 99.9%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: SPF-Wistar, Chbb: THOM
- Source: Dr. K. Thomae GmbH, D-88400 Biberach/Riss, Germany
- Age: 7 weeks
- Weight at study initiation: mean body weight male: 238 g; female: 170 g
- Housing: individually in wire cages in the inhalation chamber
- Diet (ad libitum): KLIBA rat/mouse laboratory diet 24-343-4 (Klingentalmühle, AG, CH-4303 Kaiseraugust, CH)
- Water (ad libitum): tap water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- The different 2-Ethylhexanol (2-EH) inhalation chamber concentrations were achieved by conveying the substance via continuously operating metering pumps to evaporators. For 15, 40 and 120 ppm 2-EH the vapour generation was carried out in a thermostated glass container (maintained at 46.4- 50.4°C) with a downstream mixing unit. 40 and 120 ppm atmospheres were generated by means of a two-component atomizer using compressed air and evaporation of the 2-EH-aerosol. The warmed air of the control group (45.7°C) and the vapour-air mixture of the 2-EH groups were then mixed with the overall stream and distributed to a horizontal-flow whole-body exposure system (inhalation chamber glass/steel construction with volumes of approx. 1.1 m³ manufactured by BASF AG, Ludwigshafen, Germany). In the inhalation chamber of the control group, the exhaust air system was set lower (positive pressure), in the 2-EH inhalation chambers the exhaust air system was set higher than the supply air system (negative pressure). Pressure (mean chamber pressure from - 10.2 to 10.1 Pascal) and temperature (mean temperature 23.1°C to 23.8°C) were measured continuously. The relative humidity (mean relative humidity 41.8% to 46.2%) was checked and recorded once daily.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples of the inhalation atmospheres were analyzed at intervals of about 15 min by gas chromatography (Hewlett Packard gas chromatograph Model HP 5880 A with automatic sampler HP 7671 A, FID, column: 1 m x 2 mm with 10% Triton x 305 on Supelcoport, 102/ 120 rnesh, oven temperature: 120°C. C15-paraffin was used as internal standard).
- Duration of treatment / exposure:
- 6 h on workdays over a period of 90 days (65 exposures)
- Frequency of treatment:
- 5 days/week
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
120 ppm
Basis:
- Remarks:
- Doses / Concentrations:
40 ppm
Basis:
- Remarks:
- Doses / Concentrations:
15 ppm
Basis:
- No. of animals per sex per dose:
- 10 m/10 f per group
- Control animals:
- yes, concurrent no treatment
Examinations
- Observations and examinations performed and frequency:
- Individual body weights: beginning of the preflow period, 1 day before commencement of the exposure period and weekly throughout the study.
Body weight gain: The difference between the body weight on the day of weighing and that of the preceding weighing was calculated as group mean average.
Clinical signs and mortality: daily
Ophthalmological examinations: prior to the beginning of the preflow period and at the termination of the study using an ophthalmoscope.
Blood for clinical pathology testing was collected in randomized order by retro-orbital bleeding.
Haematology: white blood cells, red blood cells, haemoglobin, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, platelets, differential blood count – on day 94 of the study
Clinical chemistry: sodium, potassium, chloride, inorganic phosphate, calcium, urea , creatinine, glucose, total bilirubin, total protein, albumin, globulins, triglycerides, cholesterol, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase - on day 94 of the study - Sacrifice and pathology:
- At the end of the 90-day exposure period all animals were necropsied and assessed by gross pathology. The body weight and the weight of the lungs, liver, kidneys, adrenal glands and testes were determined. Organs or tissues required by guidelines to be tested as well as all gross lesions were fixed in a 4% formaldehyde solution.
Histological examination and assessment of findings were carried out after histotechnical processing and staining with haematoxylin and eosin. - Statistics:
- Mean values and standard deviation were calculated for body weight and body weight change, haematological and clinical biochemistry parameters as well as for absolute and relative organ weights. The organ weights were statistically evaluated using the Dunnett's test (Dunnett 1955 and 1964) for comparison of the exposure groups with the control group. The analysis of variance (Cochran, 1957) with subsequent Dunnett's test (Dunnett 1955 and 1964) was used to compare body weight, body weight change as well as haematological and clinical biochemistry data of the treatment groups with those of the control group.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- not dose-related and therefore of no toxicological relevance
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Details on results:
- Analysis of the daily inhalation chamber concentrations revealed that the values obtained closely fitted with the desired nominal level.
There were no effects regarding clinical signs; mortality; body weight gain; ophthalmoscopic examination; haematology; clinical chemistry; organ weights; histopathology at any dose level.
Under the conditions of the test no treatment-related toxic effects were found in male and female Wistar rats which were exposed to 2-ethylhexanol vapor up to 120 ppm, corresponding to 638.4 mg/m³. The concentration of 120 ppm corresponds to the calculated saturated vapor concentration at 20°C.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 120 ppm (analytical)
- Sex:
- male/female
- Basis for effect level:
- other: clinical signs; mortality; body weight gain; ophthalmoscopic examination; haematology; clinical chemistry; organ weights; histopathology
- Dose descriptor:
- NOAEL
- Effect level:
- 638.4 mg/m³ air (analytical)
- Sex:
- male/female
- Basis for effect level:
- other: clinical signs; mortality; body weight gain; ophthalmoscopic examination; haematology; clinical chemistry; organ weights; histopathology
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Based on these results, for male and female Wistar rats the NOAEL of inhaled EH was 120 ppm corresponding to 638.4 mg/m³.
- Executive summary:
A 90-day subchronic inhalation toxicity study was performed on Wistar rats in accordance to OECD testing guidelines to evaluate the toxicological profile of 2-ethylhexanol, potential target organs, and a no-observable-adverse-effect-level (NOAEL). 10 males and 10 females per group were exposed to 2-ethylhexanol vapours at concentrations of 15, 40 and 120 ppm (the latter corresponding to the vapour saturation at 20°C) 6 hours/day for 90 days. The respective controls inhaled clean air under the same conditions. No substance-related adverse effects were observed for body weight, body weight gain, mortality, organ weights, clinical biochemistry and haematological parameters including clotting time. There were no findings related to the treatment with 2 -ethylhexanol either at necropsy or at histological examination. The highest concentration tested under these conditions (120 ppm corresponding to 638.4 mg/m³) was found to be the NOAEL for male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Hoewel ECHA veel materiaa in uw taal online heeft, is een deel van deze pagina in het Engels. Meer informatie van ECHA over meertaligheid.
Welkom op de ECHA-website. In Internet Explorer 7 (en vroegere versies) wordt deze site niet volledig ondersteund. U schakelt het best op een recentere versie van Internet Explorer over.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Lees meer over hoe wij cookies gebruiken.